nodes	percent_of_prediction	percent_of_DWPC	metapath
Indapamide—CYP3A4—prostate cancer	0.169	1	CbGaD
Indapamide—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0573	0.207	CbGbCtD
Indapamide—CYP3A4—Bicalutamide—prostate cancer	0.0301	0.109	CbGbCtD
Indapamide—CYP3A4—Estramustine—prostate cancer	0.028	0.101	CbGbCtD
Indapamide—CYP3A4—Flutamide—prostate cancer	0.0249	0.09	CbGbCtD
Indapamide—CYP3A4—Abiraterone—prostate cancer	0.0249	0.09	CbGbCtD
Indapamide—CYP3A4—Cabazitaxel—prostate cancer	0.0184	0.0666	CbGbCtD
Indapamide—CYP3A4—Estrone—prostate cancer	0.018	0.0651	CbGbCtD
Indapamide—CYP3A4—Ethinyl Estradiol—prostate cancer	0.0161	0.058	CbGbCtD
Indapamide—CYP3A4—Conjugated Estrogens—prostate cancer	0.0118	0.0426	CbGbCtD
Indapamide—CYP3A4—Mitoxantrone—prostate cancer	0.0107	0.0387	CbGbCtD
Indapamide—CYP3A4—Estradiol—prostate cancer	0.0104	0.0374	CbGbCtD
Indapamide—CYP3A4—Prednisone—prostate cancer	0.0089	0.0321	CbGbCtD
Indapamide—CYP3A4—Etoposide—prostate cancer	0.00676	0.0244	CbGbCtD
Indapamide—CYP3A4—Docetaxel—prostate cancer	0.00619	0.0223	CbGbCtD
Indapamide—KCNE1—renal system—prostate cancer	0.00594	0.0969	CbGeAlD
Indapamide—CYP3A4—Doxorubicin—prostate cancer	0.00461	0.0166	CbGbCtD
Indapamide—KCNQ1—prostate gland—prostate cancer	0.004	0.0653	CbGeAlD
Indapamide—KCNE1—testis—prostate cancer	0.00384	0.0626	CbGeAlD
Indapamide—KCNQ1—seminal vesicle—prostate cancer	0.00339	0.0552	CbGeAlD
Indapamide—CA7—renal system—prostate cancer	0.003	0.0489	CbGeAlD
Indapamide—SLC12A3—renal system—prostate cancer	0.00294	0.0479	CbGeAlD
Indapamide—KCNQ1—renal system—prostate cancer	0.00273	0.0445	CbGeAlD
Indapamide—KCNQ1—urethra—prostate cancer	0.00268	0.0437	CbGeAlD
Indapamide—Bumetanide—SLC12A2—prostate cancer	0.00265	0.638	CrCbGaD
Indapamide—CYP3A4—urine—prostate cancer	0.00264	0.043	CbGeAlD
Indapamide—CA5B—prostate gland—prostate cancer	0.00256	0.0418	CbGeAlD
Indapamide—KCNQ1—bone marrow—prostate cancer	0.00206	0.0336	CbGeAlD
Indapamide—CA12—renal system—prostate cancer	0.00195	0.0317	CbGeAlD
Indapamide—CA4—prostate gland—prostate cancer	0.00177	0.0288	CbGeAlD
Indapamide—KCNQ1—testis—prostate cancer	0.00176	0.0288	CbGeAlD
Indapamide—CA5B—urethra—prostate cancer	0.00172	0.028	CbGeAlD
Indapamide—CA9—testis—prostate cancer	0.0017	0.0277	CbGeAlD
Indapamide—CA4—seminal vesicle—prostate cancer	0.0015	0.0244	CbGeAlD
Indapamide—CA2—prostate gland—prostate cancer	0.00147	0.0239	CbGeAlD
Indapamide—KCNQ1—lymph node—prostate cancer	0.00128	0.0208	CbGeAlD
Indapamide—CA2—seminal vesicle—prostate cancer	0.00124	0.0202	CbGeAlD
Indapamide—CA4—renal system—prostate cancer	0.00121	0.0197	CbGeAlD
Indapamide—CA4—urethra—prostate cancer	0.00118	0.0193	CbGeAlD
Indapamide—CA5B—testis—prostate cancer	0.00113	0.0184	CbGeAlD
Indapamide—CA2—epithelium—prostate cancer	0.00108	0.0176	CbGeAlD
Indapamide—CA2—renal system—prostate cancer	0.000999	0.0163	CbGeAlD
Indapamide—CA4—bone marrow—prostate cancer	0.000911	0.0149	CbGeAlD
Indapamide—CA5B—lymph node—prostate cancer	0.000818	0.0133	CbGeAlD
Indapamide—CA4—testis—prostate cancer	0.000779	0.0127	CbGeAlD
Indapamide—CA2—bone marrow—prostate cancer	0.000756	0.0123	CbGeAlD
Indapamide—CA2—testis—prostate cancer	0.000646	0.0105	CbGeAlD
Indapamide—CYP3A4—renal system—prostate cancer	0.000645	0.0105	CbGeAlD
Indapamide—Oxcarbazepine—CYP3A5—prostate cancer	0.000568	0.137	CrCbGaD
Indapamide—CA4—lymph node—prostate cancer	0.000565	0.00921	CbGeAlD
Indapamide—CA2—lymph node—prostate cancer	0.000468	0.00763	CbGeAlD
Indapamide—Oxcarbazepine—CYP2C19—prostate cancer	0.000387	0.093	CrCbGaD
Indapamide—Bumetanide—PTGS2—prostate cancer	0.000303	0.0729	CrCbGaD
Indapamide—Oxcarbazepine—CYP3A4—prostate cancer	0.000246	0.0592	CrCbGaD
Indapamide—Nausea—Estradiol—prostate cancer	5.51e-05	0.000166	CcSEcCtD
Indapamide—Vomiting—Mitoxantrone—prostate cancer	5.49e-05	0.000166	CcSEcCtD
Indapamide—Sinusitis—Doxorubicin—prostate cancer	5.48e-05	0.000166	CcSEcCtD
Indapamide—Visual impairment—Epirubicin—prostate cancer	5.46e-05	0.000165	CcSEcCtD
Indapamide—Agranulocytosis—Doxorubicin—prostate cancer	5.45e-05	0.000165	CcSEcCtD
Indapamide—Rash—Mitoxantrone—prostate cancer	5.45e-05	0.000165	CcSEcCtD
Indapamide—Dermatitis—Mitoxantrone—prostate cancer	5.44e-05	0.000164	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Docetaxel—prostate cancer	5.44e-05	0.000164	CcSEcCtD
Indapamide—Headache—Mitoxantrone—prostate cancer	5.41e-05	0.000164	CcSEcCtD
Indapamide—Hypotension—Capecitabine—prostate cancer	5.4e-05	0.000163	CcSEcCtD
Indapamide—Insomnia—Docetaxel—prostate cancer	5.4e-05	0.000163	CcSEcCtD
Indapamide—Arthralgia—Prednisone—prostate cancer	5.37e-05	0.000162	CcSEcCtD
Indapamide—Myalgia—Prednisone—prostate cancer	5.37e-05	0.000162	CcSEcCtD
Indapamide—Paraesthesia—Docetaxel—prostate cancer	5.36e-05	0.000162	CcSEcCtD
Indapamide—Erythema multiforme—Epirubicin—prostate cancer	5.36e-05	0.000162	CcSEcCtD
Indapamide—Anxiety—Prednisone—prostate cancer	5.35e-05	0.000162	CcSEcCtD
Indapamide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	5.33e-05	0.000161	CcSEcCtD
Indapamide—Dyspnoea—Docetaxel—prostate cancer	5.32e-05	0.000161	CcSEcCtD
Indapamide—Somnolence—Docetaxel—prostate cancer	5.31e-05	0.00016	CcSEcCtD
Indapamide—Discomfort—Prednisone—prostate cancer	5.31e-05	0.00016	CcSEcCtD
Indapamide—Hypersensitivity—Etoposide—prostate cancer	5.29e-05	0.00016	CcSEcCtD
Indapamide—Tinnitus—Epirubicin—prostate cancer	5.28e-05	0.00016	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Capecitabine—prostate cancer	5.27e-05	0.000159	CcSEcCtD
Indapamide—Flushing—Epirubicin—prostate cancer	5.26e-05	0.000159	CcSEcCtD
Indapamide—Cardiac disorder—Epirubicin—prostate cancer	5.26e-05	0.000159	CcSEcCtD
Indapamide—Rhinitis—Doxorubicin—prostate cancer	5.26e-05	0.000159	CcSEcCtD
Indapamide—Dyspepsia—Docetaxel—prostate cancer	5.26e-05	0.000159	CcSEcCtD
Indapamide—Hepatitis—Doxorubicin—prostate cancer	5.24e-05	0.000159	CcSEcCtD
Indapamide—Insomnia—Capecitabine—prostate cancer	5.23e-05	0.000158	CcSEcCtD
Indapamide—Hypoaesthesia—Doxorubicin—prostate cancer	5.22e-05	0.000158	CcSEcCtD
Indapamide—Pharyngitis—Doxorubicin—prostate cancer	5.21e-05	0.000157	CcSEcCtD
Indapamide—Paraesthesia—Capecitabine—prostate cancer	5.19e-05	0.000157	CcSEcCtD
Indapamide—Decreased appetite—Docetaxel—prostate cancer	5.19e-05	0.000157	CcSEcCtD
Indapamide—Urinary tract disorder—Doxorubicin—prostate cancer	5.18e-05	0.000157	CcSEcCtD
Indapamide—Oedema peripheral—Doxorubicin—prostate cancer	5.17e-05	0.000156	CcSEcCtD
Indapamide—Gastrointestinal disorder—Docetaxel—prostate cancer	5.15e-05	0.000156	CcSEcCtD
Indapamide—Asthenia—Etoposide—prostate cancer	5.15e-05	0.000156	CcSEcCtD
Indapamide—Dyspnoea—Capecitabine—prostate cancer	5.15e-05	0.000156	CcSEcCtD
Indapamide—Oedema—Prednisone—prostate cancer	5.15e-05	0.000156	CcSEcCtD
Indapamide—Anaphylactic shock—Prednisone—prostate cancer	5.15e-05	0.000156	CcSEcCtD
Indapamide—Fatigue—Docetaxel—prostate cancer	5.15e-05	0.000156	CcSEcCtD
Indapamide—Urethral disorder—Doxorubicin—prostate cancer	5.14e-05	0.000155	CcSEcCtD
Indapamide—Nausea—Mitoxantrone—prostate cancer	5.13e-05	0.000155	CcSEcCtD
Indapamide—Infection—Prednisone—prostate cancer	5.12e-05	0.000155	CcSEcCtD
Indapamide—Pain—Docetaxel—prostate cancer	5.11e-05	0.000154	CcSEcCtD
Indapamide—Constipation—Docetaxel—prostate cancer	5.11e-05	0.000154	CcSEcCtD
Indapamide—Dyspepsia—Capecitabine—prostate cancer	5.09e-05	0.000154	CcSEcCtD
Indapamide—Pruritus—Etoposide—prostate cancer	5.08e-05	0.000154	CcSEcCtD
Indapamide—Shock—Prednisone—prostate cancer	5.07e-05	0.000153	CcSEcCtD
Indapamide—Arrhythmia—Epirubicin—prostate cancer	5.06e-05	0.000153	CcSEcCtD
Indapamide—Visual impairment—Doxorubicin—prostate cancer	5.05e-05	0.000153	CcSEcCtD
Indapamide—Nervous system disorder—Prednisone—prostate cancer	5.05e-05	0.000153	CcSEcCtD
Indapamide—Tachycardia—Prednisone—prostate cancer	5.03e-05	0.000152	CcSEcCtD
Indapamide—Decreased appetite—Capecitabine—prostate cancer	5.02e-05	0.000152	CcSEcCtD
Indapamide—Skin disorder—Prednisone—prostate cancer	5e-05	0.000151	CcSEcCtD
Indapamide—Gastrointestinal disorder—Capecitabine—prostate cancer	4.99e-05	0.000151	CcSEcCtD
Indapamide—Fatigue—Capecitabine—prostate cancer	4.98e-05	0.000151	CcSEcCtD
Indapamide—Hyperhidrosis—Prednisone—prostate cancer	4.98e-05	0.00015	CcSEcCtD
Indapamide—Erythema multiforme—Doxorubicin—prostate cancer	4.96e-05	0.00015	CcSEcCtD
Indapamide—Pain—Capecitabine—prostate cancer	4.94e-05	0.000149	CcSEcCtD
Indapamide—Constipation—Capecitabine—prostate cancer	4.94e-05	0.000149	CcSEcCtD
Indapamide—Erythema—Epirubicin—prostate cancer	4.93e-05	0.000149	CcSEcCtD
Indapamide—Malnutrition—Epirubicin—prostate cancer	4.93e-05	0.000149	CcSEcCtD
Indapamide—Feeling abnormal—Docetaxel—prostate cancer	4.92e-05	0.000149	CcSEcCtD
Indapamide—Diarrhoea—Etoposide—prostate cancer	4.92e-05	0.000149	CcSEcCtD
Indapamide—Anorexia—Prednisone—prostate cancer	4.91e-05	0.000148	CcSEcCtD
Indapamide—Tinnitus—Doxorubicin—prostate cancer	4.89e-05	0.000148	CcSEcCtD
Indapamide—Gastrointestinal pain—Docetaxel—prostate cancer	4.88e-05	0.000148	CcSEcCtD
Indapamide—Flushing—Doxorubicin—prostate cancer	4.87e-05	0.000147	CcSEcCtD
Indapamide—Cardiac disorder—Doxorubicin—prostate cancer	4.87e-05	0.000147	CcSEcCtD
Indapamide—Flatulence—Epirubicin—prostate cancer	4.86e-05	0.000147	CcSEcCtD
Indapamide—Tension—Epirubicin—prostate cancer	4.84e-05	0.000146	CcSEcCtD
Indapamide—Dysgeusia—Epirubicin—prostate cancer	4.83e-05	0.000146	CcSEcCtD
Indapamide—Nervousness—Epirubicin—prostate cancer	4.79e-05	0.000145	CcSEcCtD
Indapamide—Back pain—Epirubicin—prostate cancer	4.77e-05	0.000144	CcSEcCtD
Indapamide—Feeling abnormal—Capecitabine—prostate cancer	4.76e-05	0.000144	CcSEcCtD
Indapamide—Dizziness—Etoposide—prostate cancer	4.75e-05	0.000144	CcSEcCtD
Indapamide—Muscle spasms—Epirubicin—prostate cancer	4.74e-05	0.000143	CcSEcCtD
Indapamide—Gastrointestinal pain—Capecitabine—prostate cancer	4.73e-05	0.000143	CcSEcCtD
Indapamide—Abdominal pain—Docetaxel—prostate cancer	4.72e-05	0.000143	CcSEcCtD
Indapamide—Body temperature increased—Docetaxel—prostate cancer	4.72e-05	0.000143	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Prednisone—prostate cancer	4.69e-05	0.000142	CcSEcCtD
Indapamide—Arrhythmia—Doxorubicin—prostate cancer	4.69e-05	0.000142	CcSEcCtD
Indapamide—Insomnia—Prednisone—prostate cancer	4.66e-05	0.000141	CcSEcCtD
Indapamide—Vision blurred—Epirubicin—prostate cancer	4.65e-05	0.000141	CcSEcCtD
Indapamide—Paraesthesia—Prednisone—prostate cancer	4.62e-05	0.00014	CcSEcCtD
Indapamide—Urticaria—Capecitabine—prostate cancer	4.59e-05	0.000139	CcSEcCtD
Indapamide—Ill-defined disorder—Epirubicin—prostate cancer	4.58e-05	0.000138	CcSEcCtD
Indapamide—Abdominal pain—Capecitabine—prostate cancer	4.57e-05	0.000138	CcSEcCtD
Indapamide—Body temperature increased—Capecitabine—prostate cancer	4.57e-05	0.000138	CcSEcCtD
Indapamide—Vomiting—Etoposide—prostate cancer	4.57e-05	0.000138	CcSEcCtD
Indapamide—Malnutrition—Doxorubicin—prostate cancer	4.57e-05	0.000138	CcSEcCtD
Indapamide—Erythema—Doxorubicin—prostate cancer	4.57e-05	0.000138	CcSEcCtD
Indapamide—Anaemia—Epirubicin—prostate cancer	4.56e-05	0.000138	CcSEcCtD
Indapamide—Agitation—Epirubicin—prostate cancer	4.53e-05	0.000137	CcSEcCtD
Indapamide—Dyspepsia—Prednisone—prostate cancer	4.53e-05	0.000137	CcSEcCtD
Indapamide—Rash—Etoposide—prostate cancer	4.53e-05	0.000137	CcSEcCtD
Indapamide—Dermatitis—Etoposide—prostate cancer	4.53e-05	0.000137	CcSEcCtD
Indapamide—Headache—Etoposide—prostate cancer	4.5e-05	0.000136	CcSEcCtD
Indapamide—Flatulence—Doxorubicin—prostate cancer	4.5e-05	0.000136	CcSEcCtD
Indapamide—Tension—Doxorubicin—prostate cancer	4.48e-05	0.000135	CcSEcCtD
Indapamide—Decreased appetite—Prednisone—prostate cancer	4.48e-05	0.000135	CcSEcCtD
Indapamide—Dysgeusia—Doxorubicin—prostate cancer	4.47e-05	0.000135	CcSEcCtD
Indapamide—Malaise—Epirubicin—prostate cancer	4.45e-05	0.000135	CcSEcCtD
Indapamide—Fatigue—Prednisone—prostate cancer	4.44e-05	0.000134	CcSEcCtD
Indapamide—Nervousness—Doxorubicin—prostate cancer	4.43e-05	0.000134	CcSEcCtD
Indapamide—Vertigo—Epirubicin—prostate cancer	4.43e-05	0.000134	CcSEcCtD
Indapamide—Syncope—Epirubicin—prostate cancer	4.42e-05	0.000134	CcSEcCtD
Indapamide—Leukopenia—Epirubicin—prostate cancer	4.42e-05	0.000134	CcSEcCtD
Indapamide—Back pain—Doxorubicin—prostate cancer	4.42e-05	0.000134	CcSEcCtD
Indapamide—Constipation—Prednisone—prostate cancer	4.4e-05	0.000133	CcSEcCtD
Indapamide—Hypersensitivity—Docetaxel—prostate cancer	4.4e-05	0.000133	CcSEcCtD
Indapamide—Muscle spasms—Doxorubicin—prostate cancer	4.39e-05	0.000133	CcSEcCtD
Indapamide—Palpitations—Epirubicin—prostate cancer	4.36e-05	0.000132	CcSEcCtD
Indapamide—Loss of consciousness—Epirubicin—prostate cancer	4.34e-05	0.000131	CcSEcCtD
Indapamide—Cough—Epirubicin—prostate cancer	4.31e-05	0.00013	CcSEcCtD
Indapamide—Vision blurred—Doxorubicin—prostate cancer	4.3e-05	0.00013	CcSEcCtD
Indapamide—Asthenia—Docetaxel—prostate cancer	4.28e-05	0.00013	CcSEcCtD
Indapamide—Nausea—Etoposide—prostate cancer	4.27e-05	0.000129	CcSEcCtD
Indapamide—Hypersensitivity—Capecitabine—prostate cancer	4.26e-05	0.000129	CcSEcCtD
Indapamide—Feeling abnormal—Prednisone—prostate cancer	4.24e-05	0.000128	CcSEcCtD
Indapamide—Ill-defined disorder—Doxorubicin—prostate cancer	4.24e-05	0.000128	CcSEcCtD
Indapamide—Pruritus—Docetaxel—prostate cancer	4.22e-05	0.000128	CcSEcCtD
Indapamide—Anaemia—Doxorubicin—prostate cancer	4.22e-05	0.000128	CcSEcCtD
Indapamide—Gastrointestinal pain—Prednisone—prostate cancer	4.21e-05	0.000127	CcSEcCtD
Indapamide—Myalgia—Epirubicin—prostate cancer	4.2e-05	0.000127	CcSEcCtD
Indapamide—Arthralgia—Epirubicin—prostate cancer	4.2e-05	0.000127	CcSEcCtD
Indapamide—Chest pain—Epirubicin—prostate cancer	4.2e-05	0.000127	CcSEcCtD
Indapamide—Agitation—Doxorubicin—prostate cancer	4.2e-05	0.000127	CcSEcCtD
Indapamide—Anxiety—Epirubicin—prostate cancer	4.19e-05	0.000127	CcSEcCtD
Indapamide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	4.17e-05	0.000126	CcSEcCtD
Indapamide—Discomfort—Epirubicin—prostate cancer	4.15e-05	0.000125	CcSEcCtD
Indapamide—Asthenia—Capecitabine—prostate cancer	4.15e-05	0.000125	CcSEcCtD
Indapamide—Malaise—Doxorubicin—prostate cancer	4.12e-05	0.000124	CcSEcCtD
Indapamide—Dry mouth—Epirubicin—prostate cancer	4.11e-05	0.000124	CcSEcCtD
Indapamide—Vertigo—Doxorubicin—prostate cancer	4.1e-05	0.000124	CcSEcCtD
Indapamide—Syncope—Doxorubicin—prostate cancer	4.09e-05	0.000124	CcSEcCtD
Indapamide—Urticaria—Prednisone—prostate cancer	4.09e-05	0.000124	CcSEcCtD
Indapamide—Pruritus—Capecitabine—prostate cancer	4.09e-05	0.000124	CcSEcCtD
Indapamide—Leukopenia—Doxorubicin—prostate cancer	4.09e-05	0.000124	CcSEcCtD
Indapamide—Diarrhoea—Docetaxel—prostate cancer	4.08e-05	0.000123	CcSEcCtD
Indapamide—Body temperature increased—Prednisone—prostate cancer	4.07e-05	0.000123	CcSEcCtD
Indapamide—Abdominal pain—Prednisone—prostate cancer	4.07e-05	0.000123	CcSEcCtD
Indapamide—Palpitations—Doxorubicin—prostate cancer	4.03e-05	0.000122	CcSEcCtD
Indapamide—Anaphylactic shock—Epirubicin—prostate cancer	4.03e-05	0.000122	CcSEcCtD
Indapamide—Oedema—Epirubicin—prostate cancer	4.03e-05	0.000122	CcSEcCtD
Indapamide—Loss of consciousness—Doxorubicin—prostate cancer	4.01e-05	0.000121	CcSEcCtD
Indapamide—Infection—Epirubicin—prostate cancer	4e-05	0.000121	CcSEcCtD
Indapamide—Cough—Doxorubicin—prostate cancer	3.98e-05	0.00012	CcSEcCtD
Indapamide—Shock—Epirubicin—prostate cancer	3.96e-05	0.00012	CcSEcCtD
Indapamide—Diarrhoea—Capecitabine—prostate cancer	3.95e-05	0.00012	CcSEcCtD
Indapamide—Nervous system disorder—Epirubicin—prostate cancer	3.95e-05	0.000119	CcSEcCtD
Indapamide—Dizziness—Docetaxel—prostate cancer	3.95e-05	0.000119	CcSEcCtD
Indapamide—Thrombocytopenia—Epirubicin—prostate cancer	3.94e-05	0.000119	CcSEcCtD
Indapamide—Tachycardia—Epirubicin—prostate cancer	3.93e-05	0.000119	CcSEcCtD
Indapamide—Skin disorder—Epirubicin—prostate cancer	3.91e-05	0.000118	CcSEcCtD
Indapamide—Hyperhidrosis—Epirubicin—prostate cancer	3.89e-05	0.000118	CcSEcCtD
Indapamide—Chest pain—Doxorubicin—prostate cancer	3.89e-05	0.000118	CcSEcCtD
Indapamide—Myalgia—Doxorubicin—prostate cancer	3.89e-05	0.000118	CcSEcCtD
Indapamide—Arthralgia—Doxorubicin—prostate cancer	3.89e-05	0.000118	CcSEcCtD
Indapamide—Anxiety—Doxorubicin—prostate cancer	3.87e-05	0.000117	CcSEcCtD
Indapamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	3.86e-05	0.000117	CcSEcCtD
Indapamide—Discomfort—Doxorubicin—prostate cancer	3.84e-05	0.000116	CcSEcCtD
Indapamide—Anorexia—Epirubicin—prostate cancer	3.84e-05	0.000116	CcSEcCtD
Indapamide—Dizziness—Capecitabine—prostate cancer	3.82e-05	0.000116	CcSEcCtD
Indapamide—Dry mouth—Doxorubicin—prostate cancer	3.8e-05	0.000115	CcSEcCtD
Indapamide—Vomiting—Docetaxel—prostate cancer	3.8e-05	0.000115	CcSEcCtD
Indapamide—Hypersensitivity—Prednisone—prostate cancer	3.79e-05	0.000115	CcSEcCtD
Indapamide—Rash—Docetaxel—prostate cancer	3.76e-05	0.000114	CcSEcCtD
Indapamide—Hypotension—Epirubicin—prostate cancer	3.76e-05	0.000114	CcSEcCtD
Indapamide—Dermatitis—Docetaxel—prostate cancer	3.76e-05	0.000114	CcSEcCtD
Indapamide—Headache—Docetaxel—prostate cancer	3.74e-05	0.000113	CcSEcCtD
Indapamide—Anaphylactic shock—Doxorubicin—prostate cancer	3.73e-05	0.000113	CcSEcCtD
Indapamide—Oedema—Doxorubicin—prostate cancer	3.73e-05	0.000113	CcSEcCtD
Indapamide—Infection—Doxorubicin—prostate cancer	3.7e-05	0.000112	CcSEcCtD
Indapamide—Asthenia—Prednisone—prostate cancer	3.69e-05	0.000112	CcSEcCtD
Indapamide—Vomiting—Capecitabine—prostate cancer	3.68e-05	0.000111	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Epirubicin—prostate cancer	3.67e-05	0.000111	CcSEcCtD
Indapamide—Shock—Doxorubicin—prostate cancer	3.67e-05	0.000111	CcSEcCtD
Indapamide—Nervous system disorder—Doxorubicin—prostate cancer	3.65e-05	0.00011	CcSEcCtD
Indapamide—Thrombocytopenia—Doxorubicin—prostate cancer	3.65e-05	0.00011	CcSEcCtD
Indapamide—Rash—Capecitabine—prostate cancer	3.64e-05	0.00011	CcSEcCtD
Indapamide—Pruritus—Prednisone—prostate cancer	3.64e-05	0.00011	CcSEcCtD
Indapamide—Insomnia—Epirubicin—prostate cancer	3.64e-05	0.00011	CcSEcCtD
Indapamide—Dermatitis—Capecitabine—prostate cancer	3.64e-05	0.00011	CcSEcCtD
Indapamide—Tachycardia—Doxorubicin—prostate cancer	3.64e-05	0.00011	CcSEcCtD
Indapamide—Headache—Capecitabine—prostate cancer	3.62e-05	0.000109	CcSEcCtD
Indapamide—Skin disorder—Doxorubicin—prostate cancer	3.62e-05	0.000109	CcSEcCtD
Indapamide—Paraesthesia—Epirubicin—prostate cancer	3.62e-05	0.000109	CcSEcCtD
Indapamide—Hyperhidrosis—Doxorubicin—prostate cancer	3.6e-05	0.000109	CcSEcCtD
Indapamide—Dyspnoea—Epirubicin—prostate cancer	3.59e-05	0.000109	CcSEcCtD
Indapamide—Somnolence—Epirubicin—prostate cancer	3.58e-05	0.000108	CcSEcCtD
Indapamide—Anorexia—Doxorubicin—prostate cancer	3.55e-05	0.000107	CcSEcCtD
Indapamide—Nausea—Docetaxel—prostate cancer	3.55e-05	0.000107	CcSEcCtD
Indapamide—Dyspepsia—Epirubicin—prostate cancer	3.54e-05	0.000107	CcSEcCtD
Indapamide—Diarrhoea—Prednisone—prostate cancer	3.52e-05	0.000107	CcSEcCtD
Indapamide—Decreased appetite—Epirubicin—prostate cancer	3.5e-05	0.000106	CcSEcCtD
Indapamide—Hypotension—Doxorubicin—prostate cancer	3.48e-05	0.000105	CcSEcCtD
Indapamide—Gastrointestinal disorder—Epirubicin—prostate cancer	3.48e-05	0.000105	CcSEcCtD
Indapamide—Fatigue—Epirubicin—prostate cancer	3.47e-05	0.000105	CcSEcCtD
Indapamide—Pain—Epirubicin—prostate cancer	3.44e-05	0.000104	CcSEcCtD
Indapamide—Constipation—Epirubicin—prostate cancer	3.44e-05	0.000104	CcSEcCtD
Indapamide—Nausea—Capecitabine—prostate cancer	3.43e-05	0.000104	CcSEcCtD
Indapamide—Dizziness—Prednisone—prostate cancer	3.4e-05	0.000103	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Doxorubicin—prostate cancer	3.39e-05	0.000103	CcSEcCtD
Indapamide—Insomnia—Doxorubicin—prostate cancer	3.37e-05	0.000102	CcSEcCtD
Indapamide—Paraesthesia—Doxorubicin—prostate cancer	3.35e-05	0.000101	CcSEcCtD
Indapamide—Dyspnoea—Doxorubicin—prostate cancer	3.32e-05	0.0001	CcSEcCtD
Indapamide—Feeling abnormal—Epirubicin—prostate cancer	3.32e-05	0.0001	CcSEcCtD
Indapamide—Somnolence—Doxorubicin—prostate cancer	3.31e-05	0.0001	CcSEcCtD
Indapamide—Gastrointestinal pain—Epirubicin—prostate cancer	3.29e-05	9.96e-05	CcSEcCtD
Indapamide—Dyspepsia—Doxorubicin—prostate cancer	3.28e-05	9.92e-05	CcSEcCtD
Indapamide—Vomiting—Prednisone—prostate cancer	3.27e-05	9.9e-05	CcSEcCtD
Indapamide—Rash—Prednisone—prostate cancer	3.25e-05	9.81e-05	CcSEcCtD
Indapamide—Dermatitis—Prednisone—prostate cancer	3.24e-05	9.81e-05	CcSEcCtD
Indapamide—Decreased appetite—Doxorubicin—prostate cancer	3.24e-05	9.79e-05	CcSEcCtD
Indapamide—Headache—Prednisone—prostate cancer	3.23e-05	9.75e-05	CcSEcCtD
Indapamide—Gastrointestinal disorder—Doxorubicin—prostate cancer	3.22e-05	9.73e-05	CcSEcCtD
Indapamide—Fatigue—Doxorubicin—prostate cancer	3.21e-05	9.71e-05	CcSEcCtD
Indapamide—Urticaria—Epirubicin—prostate cancer	3.2e-05	9.67e-05	CcSEcCtD
Indapamide—Constipation—Doxorubicin—prostate cancer	3.19e-05	9.63e-05	CcSEcCtD
Indapamide—Pain—Doxorubicin—prostate cancer	3.19e-05	9.63e-05	CcSEcCtD
Indapamide—Body temperature increased—Epirubicin—prostate cancer	3.18e-05	9.62e-05	CcSEcCtD
Indapamide—Abdominal pain—Epirubicin—prostate cancer	3.18e-05	9.62e-05	CcSEcCtD
Indapamide—Feeling abnormal—Doxorubicin—prostate cancer	3.07e-05	9.28e-05	CcSEcCtD
Indapamide—Nausea—Prednisone—prostate cancer	3.06e-05	9.25e-05	CcSEcCtD
Indapamide—Gastrointestinal pain—Doxorubicin—prostate cancer	3.05e-05	9.21e-05	CcSEcCtD
Indapamide—Hypersensitivity—Epirubicin—prostate cancer	2.97e-05	8.97e-05	CcSEcCtD
Indapamide—Urticaria—Doxorubicin—prostate cancer	2.96e-05	8.95e-05	CcSEcCtD
Indapamide—Abdominal pain—Doxorubicin—prostate cancer	2.95e-05	8.91e-05	CcSEcCtD
Indapamide—Body temperature increased—Doxorubicin—prostate cancer	2.95e-05	8.91e-05	CcSEcCtD
Indapamide—Asthenia—Epirubicin—prostate cancer	2.89e-05	8.74e-05	CcSEcCtD
Indapamide—Pruritus—Epirubicin—prostate cancer	2.85e-05	8.61e-05	CcSEcCtD
Indapamide—Diarrhoea—Epirubicin—prostate cancer	2.76e-05	8.33e-05	CcSEcCtD
Indapamide—Hypersensitivity—Doxorubicin—prostate cancer	2.75e-05	8.3e-05	CcSEcCtD
Indapamide—Asthenia—Doxorubicin—prostate cancer	2.67e-05	8.08e-05	CcSEcCtD
Indapamide—Dizziness—Epirubicin—prostate cancer	2.66e-05	8.05e-05	CcSEcCtD
Indapamide—Pruritus—Doxorubicin—prostate cancer	2.64e-05	7.97e-05	CcSEcCtD
Indapamide—Vomiting—Epirubicin—prostate cancer	2.56e-05	7.74e-05	CcSEcCtD
Indapamide—Diarrhoea—Doxorubicin—prostate cancer	2.55e-05	7.71e-05	CcSEcCtD
Indapamide—Rash—Epirubicin—prostate cancer	2.54e-05	7.68e-05	CcSEcCtD
Indapamide—Dermatitis—Epirubicin—prostate cancer	2.54e-05	7.67e-05	CcSEcCtD
Indapamide—Headache—Epirubicin—prostate cancer	2.52e-05	7.63e-05	CcSEcCtD
Indapamide—Dizziness—Doxorubicin—prostate cancer	2.46e-05	7.45e-05	CcSEcCtD
Indapamide—Nausea—Epirubicin—prostate cancer	2.39e-05	7.23e-05	CcSEcCtD
Indapamide—Vomiting—Doxorubicin—prostate cancer	2.37e-05	7.16e-05	CcSEcCtD
Indapamide—Rash—Doxorubicin—prostate cancer	2.35e-05	7.1e-05	CcSEcCtD
Indapamide—Dermatitis—Doxorubicin—prostate cancer	2.35e-05	7.1e-05	CcSEcCtD
Indapamide—Headache—Doxorubicin—prostate cancer	2.33e-05	7.06e-05	CcSEcCtD
Indapamide—CA4—Metabolism—RXRA—prostate cancer	2.3e-05	0.000146	CbGpPWpGaD
Indapamide—CA2—Metabolism—CYP19A1—prostate cancer	2.28e-05	0.000145	CbGpPWpGaD
Indapamide—CYP3A4—Biological oxidations—NCOA2—prostate cancer	2.28e-05	0.000145	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—TP53—prostate cancer	2.28e-05	0.000145	CbGpPWpGaD
Indapamide—CA12—Metabolism—MTHFR—prostate cancer	2.25e-05	0.000143	CbGpPWpGaD
Indapamide—CA5B—Metabolism—CAV1—prostate cancer	2.24e-05	0.000142	CbGpPWpGaD
Indapamide—CA7—Metabolism—CAV1—prostate cancer	2.24e-05	0.000142	CbGpPWpGaD
Indapamide—CA4—Metabolism—COMT—prostate cancer	2.22e-05	0.000141	CbGpPWpGaD
Indapamide—Nausea—Doxorubicin—prostate cancer	2.21e-05	6.69e-05	CcSEcCtD
Indapamide—CA9—Metabolism—SLC5A5—prostate cancer	2.21e-05	0.000141	CbGpPWpGaD
Indapamide—CA4—Metabolism—GSTP1—prostate cancer	2.2e-05	0.00014	CbGpPWpGaD
Indapamide—CA2—Metabolism—RXRA—prostate cancer	2.2e-05	0.00014	CbGpPWpGaD
Indapamide—CA12—Metabolism—PPARA—prostate cancer	2.2e-05	0.00014	CbGpPWpGaD
Indapamide—CA5A—Metabolism—PIK3CG—prostate cancer	2.18e-05	0.000139	CbGpPWpGaD
Indapamide—CA4—Metabolism—ITPR1—prostate cancer	2.17e-05	0.000138	CbGpPWpGaD
Indapamide—CA9—Metabolism—CYP2E1—prostate cancer	2.16e-05	0.000137	CbGpPWpGaD
Indapamide—CA9—Metabolism—NQO1—prostate cancer	2.14e-05	0.000136	CbGpPWpGaD
Indapamide—CYP3A4—Biological oxidations—CYP2E1—prostate cancer	2.13e-05	0.000135	CbGpPWpGaD
Indapamide—CA2—Metabolism—COMT—prostate cancer	2.12e-05	0.000135	CbGpPWpGaD
Indapamide—CA2—Metabolism—GSTP1—prostate cancer	2.11e-05	0.000134	CbGpPWpGaD
Indapamide—CA9—Metabolism—TH—prostate cancer	2.11e-05	0.000134	CbGpPWpGaD
Indapamide—CYP3A4—Metapathway biotransformation—CYP2E1—prostate cancer	2.1e-05	0.000133	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—IL6—prostate cancer	2.09e-05	0.000133	CbGpPWpGaD
Indapamide—CA9—Metabolism—CYP3A4—prostate cancer	2.08e-05	0.000132	CbGpPWpGaD
Indapamide—CA2—Metabolism—ITPR1—prostate cancer	2.08e-05	0.000132	CbGpPWpGaD
Indapamide—CA12—Metabolism—CAV1—prostate cancer	2.07e-05	0.000132	CbGpPWpGaD
Indapamide—CA5A—Metabolism—INS—prostate cancer	2.06e-05	0.000131	CbGpPWpGaD
Indapamide—CA4—Metabolism—TYMS—prostate cancer	2.05e-05	0.00013	CbGpPWpGaD
Indapamide—CA9—Metabolism—CYP1B1—prostate cancer	2.05e-05	0.00013	CbGpPWpGaD
Indapamide—CA7—Metabolism—PIK3CG—prostate cancer	2.04e-05	0.000129	CbGpPWpGaD
Indapamide—CA5B—Metabolism—PIK3CG—prostate cancer	2.04e-05	0.000129	CbGpPWpGaD
Indapamide—CA4—Metabolism—GSTM1—prostate cancer	2.03e-05	0.000129	CbGpPWpGaD
Indapamide—CA5A—Metabolism—CREBBP—prostate cancer	2.02e-05	0.000129	CbGpPWpGaD
Indapamide—CYP3A4—Biological oxidations—CYP1B1—prostate cancer	2.02e-05	0.000128	CbGpPWpGaD
Indapamide—CA4—Metabolism—LPL—prostate cancer	1.99e-05	0.000126	CbGpPWpGaD
Indapamide—CYP3A4—Metapathway biotransformation—CYP1B1—prostate cancer	1.99e-05	0.000126	CbGpPWpGaD
Indapamide—CA9—Metabolism—GGT1—prostate cancer	1.98e-05	0.000126	CbGpPWpGaD
Indapamide—CA2—Metabolism—TYMS—prostate cancer	1.97e-05	0.000125	CbGpPWpGaD
Indapamide—CA9—Metabolism—NCOA1—prostate cancer	1.95e-05	0.000124	CbGpPWpGaD
Indapamide—CYP3A4—Biological oxidations—GGT1—prostate cancer	1.95e-05	0.000124	CbGpPWpGaD
Indapamide—CA2—Metabolism—GSTM1—prostate cancer	1.94e-05	0.000123	CbGpPWpGaD
Indapamide—CA7—Metabolism—INS—prostate cancer	1.93e-05	0.000123	CbGpPWpGaD
Indapamide—CA5B—Metabolism—INS—prostate cancer	1.93e-05	0.000123	CbGpPWpGaD
Indapamide—CA9—Metabolism—CYP19A1—prostate cancer	1.93e-05	0.000122	CbGpPWpGaD
Indapamide—CYP3A4—Biological oxidations—NCOA1—prostate cancer	1.92e-05	0.000122	CbGpPWpGaD
Indapamide—CA4—Metabolism—CYP1A1—prostate cancer	1.92e-05	0.000122	CbGpPWpGaD
Indapamide—CA5A—Metabolism—PIK3CD—prostate cancer	1.92e-05	0.000122	CbGpPWpGaD
Indapamide—CA2—Metabolism—LPL—prostate cancer	1.91e-05	0.000121	CbGpPWpGaD
Indapamide—CA4—Metabolism—ERCC2—prostate cancer	1.91e-05	0.000121	CbGpPWpGaD
Indapamide—CYP3A4—Biological oxidations—CYP19A1—prostate cancer	1.9e-05	0.00012	CbGpPWpGaD
Indapamide—CA7—Metabolism—CREBBP—prostate cancer	1.89e-05	0.00012	CbGpPWpGaD
Indapamide—CA5B—Metabolism—CREBBP—prostate cancer	1.89e-05	0.00012	CbGpPWpGaD
Indapamide—CA12—Metabolism—PIK3CG—prostate cancer	1.89e-05	0.00012	CbGpPWpGaD
Indapamide—CYP3A4—Metapathway biotransformation—CYP19A1—prostate cancer	1.87e-05	0.000119	CbGpPWpGaD
Indapamide—CA9—Metabolism—RXRA—prostate cancer	1.86e-05	0.000118	CbGpPWpGaD
Indapamide—CA2—Metabolism—CYP1A1—prostate cancer	1.84e-05	0.000117	CbGpPWpGaD
Indapamide—CYP3A4—Biological oxidations—RXRA—prostate cancer	1.83e-05	0.000116	CbGpPWpGaD
Indapamide—CA2—Metabolism—ERCC2—prostate cancer	1.83e-05	0.000116	CbGpPWpGaD
Indapamide—CA5A—Metabolism—NOS3—prostate cancer	1.81e-05	0.000115	CbGpPWpGaD
Indapamide—CA4—Metabolism—MTHFR—prostate cancer	1.79e-05	0.000114	CbGpPWpGaD
Indapamide—CA7—Metabolism—PIK3CD—prostate cancer	1.79e-05	0.000114	CbGpPWpGaD
Indapamide—CA5B—Metabolism—PIK3CD—prostate cancer	1.79e-05	0.000114	CbGpPWpGaD
Indapamide—CA9—Metabolism—COMT—prostate cancer	1.79e-05	0.000114	CbGpPWpGaD
Indapamide—CA12—Metabolism—INS—prostate cancer	1.79e-05	0.000114	CbGpPWpGaD
Indapamide—CA9—Metabolism—GSTP1—prostate cancer	1.78e-05	0.000113	CbGpPWpGaD
Indapamide—CYP3A4—Biological oxidations—COMT—prostate cancer	1.76e-05	0.000112	CbGpPWpGaD
Indapamide—CA4—Metabolism—PPARA—prostate cancer	1.76e-05	0.000112	CbGpPWpGaD
Indapamide—CYP3A4—Biological oxidations—GSTP1—prostate cancer	1.75e-05	0.000111	CbGpPWpGaD
Indapamide—CA9—Metabolism—ITPR1—prostate cancer	1.75e-05	0.000111	CbGpPWpGaD
Indapamide—CA12—Metabolism—CREBBP—prostate cancer	1.75e-05	0.000111	CbGpPWpGaD
Indapamide—CYP3A4—Metapathway biotransformation—COMT—prostate cancer	1.74e-05	0.00011	CbGpPWpGaD
Indapamide—CYP3A4—Metapathway biotransformation—GSTP1—prostate cancer	1.73e-05	0.00011	CbGpPWpGaD
Indapamide—CA2—Metabolism—MTHFR—prostate cancer	1.72e-05	0.000109	CbGpPWpGaD
Indapamide—CA5B—Metabolism—NOS3—prostate cancer	1.69e-05	0.000107	CbGpPWpGaD
Indapamide—CA7—Metabolism—NOS3—prostate cancer	1.69e-05	0.000107	CbGpPWpGaD
Indapamide—CA2—Metabolism—PPARA—prostate cancer	1.68e-05	0.000107	CbGpPWpGaD
Indapamide—CA5A—Metabolism—PIK3CB—prostate cancer	1.67e-05	0.000106	CbGpPWpGaD
Indapamide—CA12—Metabolism—PIK3CD—prostate cancer	1.66e-05	0.000105	CbGpPWpGaD
Indapamide—CA9—Metabolism—TYMS—prostate cancer	1.66e-05	0.000105	CbGpPWpGaD
Indapamide—CA5A—Metabolism—PTGS2—prostate cancer	1.66e-05	0.000105	CbGpPWpGaD
Indapamide—CA4—Metabolism—CAV1—prostate cancer	1.65e-05	0.000105	CbGpPWpGaD
Indapamide—CA9—Metabolism—GSTM1—prostate cancer	1.64e-05	0.000104	CbGpPWpGaD
Indapamide—CYP3A4—Biological oxidations—GSTM1—prostate cancer	1.61e-05	0.000102	CbGpPWpGaD
Indapamide—CA9—Metabolism—LPL—prostate cancer	1.61e-05	0.000102	CbGpPWpGaD
Indapamide—CYP3A4—Metapathway biotransformation—GSTM1—prostate cancer	1.59e-05	0.000101	CbGpPWpGaD
Indapamide—CA2—Metabolism—CAV1—prostate cancer	1.58e-05	0.000101	CbGpPWpGaD
Indapamide—CA12—Metabolism—NOS3—prostate cancer	1.57e-05	9.96e-05	CbGpPWpGaD
Indapamide—CA7—Metabolism—PIK3CB—prostate cancer	1.56e-05	9.92e-05	CbGpPWpGaD
Indapamide—CA5B—Metabolism—PIK3CB—prostate cancer	1.56e-05	9.92e-05	CbGpPWpGaD
Indapamide—CA9—Metabolism—CYP1A1—prostate cancer	1.55e-05	9.87e-05	CbGpPWpGaD
Indapamide—CA7—Metabolism—PTGS2—prostate cancer	1.55e-05	9.83e-05	CbGpPWpGaD
Indapamide—CA5B—Metabolism—PTGS2—prostate cancer	1.55e-05	9.83e-05	CbGpPWpGaD
Indapamide—CA9—Metabolism—ERCC2—prostate cancer	1.54e-05	9.79e-05	CbGpPWpGaD
Indapamide—CYP3A4—Biological oxidations—CYP1A1—prostate cancer	1.53e-05	9.71e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—HAO1—prostate cancer	1.51e-05	9.59e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metapathway biotransformation—CYP1A1—prostate cancer	1.51e-05	9.58e-05	CbGpPWpGaD
Indapamide—CA4—Metabolism—PIK3CG—prostate cancer	1.5e-05	9.56e-05	CbGpPWpGaD
Indapamide—CA9—Metabolism—MTHFR—prostate cancer	1.45e-05	9.2e-05	CbGpPWpGaD
Indapamide—CA12—Metabolism—PIK3CB—prostate cancer	1.45e-05	9.19e-05	CbGpPWpGaD
Indapamide—CA5A—Metabolism—PTEN—prostate cancer	1.44e-05	9.18e-05	CbGpPWpGaD
Indapamide—CA2—Metabolism—PIK3CG—prostate cancer	1.44e-05	9.17e-05	CbGpPWpGaD
Indapamide—CA12—Metabolism—PTGS2—prostate cancer	1.43e-05	9.11e-05	CbGpPWpGaD
Indapamide—CA4—Metabolism—INS—prostate cancer	1.42e-05	9.05e-05	CbGpPWpGaD
Indapamide—CA9—Metabolism—PPARA—prostate cancer	1.42e-05	9.02e-05	CbGpPWpGaD
Indapamide—CA4—Metabolism—CREBBP—prostate cancer	1.39e-05	8.87e-05	CbGpPWpGaD
Indapamide—CA5A—Metabolism—EP300—prostate cancer	1.38e-05	8.76e-05	CbGpPWpGaD
Indapamide—CA2—Metabolism—INS—prostate cancer	1.37e-05	8.68e-05	CbGpPWpGaD
Indapamide—CA5B—Metabolism—PTEN—prostate cancer	1.35e-05	8.57e-05	CbGpPWpGaD
Indapamide—CA7—Metabolism—PTEN—prostate cancer	1.35e-05	8.57e-05	CbGpPWpGaD
Indapamide—CA2—Metabolism—CREBBP—prostate cancer	1.34e-05	8.5e-05	CbGpPWpGaD
Indapamide—CA9—Metabolism—CAV1—prostate cancer	1.33e-05	8.48e-05	CbGpPWpGaD
Indapamide—CA4—Metabolism—PIK3CD—prostate cancer	1.32e-05	8.41e-05	CbGpPWpGaD
Indapamide—CA5B—Metabolism—EP300—prostate cancer	1.29e-05	8.17e-05	CbGpPWpGaD
Indapamide—CA7—Metabolism—EP300—prostate cancer	1.29e-05	8.17e-05	CbGpPWpGaD
Indapamide—CA2—Metabolism—PIK3CD—prostate cancer	1.27e-05	8.06e-05	CbGpPWpGaD
Indapamide—CA12—Metabolism—PTEN—prostate cancer	1.25e-05	7.94e-05	CbGpPWpGaD
Indapamide—CA4—Metabolism—NOS3—prostate cancer	1.25e-05	7.94e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—TST—prostate cancer	1.23e-05	7.81e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PSAT1—prostate cancer	1.23e-05	7.81e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CBR1—prostate cancer	1.23e-05	7.81e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CSAD—prostate cancer	1.23e-05	7.81e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—GRHL1—prostate cancer	1.23e-05	7.81e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—ADI1—prostate cancer	1.23e-05	7.81e-05	CbGpPWpGaD
Indapamide—CA9—Metabolism—PIK3CG—prostate cancer	1.22e-05	7.73e-05	CbGpPWpGaD
Indapamide—CA2—Metabolism—NOS3—prostate cancer	1.2e-05	7.61e-05	CbGpPWpGaD
Indapamide—CA12—Metabolism—EP300—prostate cancer	1.19e-05	7.57e-05	CbGpPWpGaD
Indapamide—CA4—Metabolism—PIK3CB—prostate cancer	1.15e-05	7.33e-05	CbGpPWpGaD
Indapamide—CA9—Metabolism—INS—prostate cancer	1.15e-05	7.32e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—UGT2B15—prostate cancer	1.14e-05	7.26e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—UGT2B17—prostate cancer	1.14e-05	7.26e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—GRHPR—prostate cancer	1.14e-05	7.26e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CKMT2—prostate cancer	1.14e-05	7.26e-05	CbGpPWpGaD
Indapamide—CA4—Metabolism—PTGS2—prostate cancer	1.14e-05	7.26e-05	CbGpPWpGaD
Indapamide—CA9—Metabolism—CREBBP—prostate cancer	1.13e-05	7.17e-05	CbGpPWpGaD
Indapamide—CA2—Metabolism—PIK3CB—prostate cancer	1.11e-05	7.03e-05	CbGpPWpGaD
Indapamide—CA2—Metabolism—PTGS2—prostate cancer	1.1e-05	6.96e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—RFK—prostate cancer	1.07e-05	6.83e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—AOX1—prostate cancer	1.07e-05	6.83e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—GSTM3—prostate cancer	1.07e-05	6.83e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—MBTPS1—prostate cancer	1.07e-05	6.83e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—NAGLU—prostate cancer	1.07e-05	6.83e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—SULT2B1—prostate cancer	1.07e-05	6.83e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PGAM2—prostate cancer	1.07e-05	6.83e-05	CbGpPWpGaD
Indapamide—CA9—Metabolism—PIK3CD—prostate cancer	1.07e-05	6.79e-05	CbGpPWpGaD
Indapamide—CA5A—Metabolism—PIK3CA—prostate cancer	1.02e-05	6.48e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CYP3A43—prostate cancer	1.02e-05	6.47e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—AMACR—prostate cancer	1.02e-05	6.47e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—DEGS1—prostate cancer	1.02e-05	6.47e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—SRD5A2—prostate cancer	1.02e-05	6.47e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—NAT1—prostate cancer	1.02e-05	6.47e-05	CbGpPWpGaD
Indapamide—CA9—Metabolism—NOS3—prostate cancer	1.01e-05	6.42e-05	CbGpPWpGaD
Indapamide—CA4—Metabolism—PTEN—prostate cancer	9.96e-06	6.33e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—HSD17B1—prostate cancer	9.72e-06	6.18e-05	CbGpPWpGaD
Indapamide—CA2—Metabolism—PTEN—prostate cancer	9.55e-06	6.07e-05	CbGpPWpGaD
Indapamide—CA5B—Metabolism—PIK3CA—prostate cancer	9.51e-06	6.05e-05	CbGpPWpGaD
Indapamide—CA7—Metabolism—PIK3CA—prostate cancer	9.51e-06	6.05e-05	CbGpPWpGaD
Indapamide—CA4—Metabolism—EP300—prostate cancer	9.5e-06	6.04e-05	CbGpPWpGaD
Indapamide—CA9—Metabolism—PIK3CB—prostate cancer	9.32e-06	5.92e-05	CbGpPWpGaD
Indapamide—CA9—Metabolism—PTGS2—prostate cancer	9.23e-06	5.87e-05	CbGpPWpGaD
Indapamide—CA2—Metabolism—EP300—prostate cancer	9.11e-06	5.79e-05	CbGpPWpGaD
Indapamide—CA12—Metabolism—PIK3CA—prostate cancer	8.81e-06	5.6e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—B4GALT4—prostate cancer	8.66e-06	5.51e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—HPGD—prostate cancer	8.66e-06	5.51e-05	CbGpPWpGaD
Indapamide—CA5A—Metabolism—AKT1—prostate cancer	8.32e-06	5.29e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—TNFRSF21—prostate cancer	8.14e-06	5.18e-05	CbGpPWpGaD
Indapamide—CA9—Metabolism—PTEN—prostate cancer	8.05e-06	5.12e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—MTAP—prostate cancer	7.92e-06	5.04e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CYP7B1—prostate cancer	7.92e-06	5.04e-05	CbGpPWpGaD
Indapamide—CA7—Metabolism—AKT1—prostate cancer	7.77e-06	4.94e-05	CbGpPWpGaD
Indapamide—CA5B—Metabolism—AKT1—prostate cancer	7.77e-06	4.94e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—SRD5A1—prostate cancer	7.72e-06	4.91e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—SULT1E1—prostate cancer	7.72e-06	4.91e-05	CbGpPWpGaD
Indapamide—CA9—Metabolism—EP300—prostate cancer	7.68e-06	4.88e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—ACSL4—prostate cancer	7.36e-06	4.68e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—HSD17B3—prostate cancer	7.36e-06	4.68e-05	CbGpPWpGaD
Indapamide—CA12—Metabolism—AKT1—prostate cancer	7.2e-06	4.58e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PHGDH—prostate cancer	7.06e-06	4.49e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—UMPS—prostate cancer	7.06e-06	4.49e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—ARG2—prostate cancer	7.06e-06	4.49e-05	CbGpPWpGaD
Indapamide—CA4—Metabolism—PIK3CA—prostate cancer	7.03e-06	4.47e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—LDHB—prostate cancer	6.92e-06	4.4e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CYP3A5—prostate cancer	6.8e-06	4.32e-05	CbGpPWpGaD
Indapamide—CA2—Metabolism—PIK3CA—prostate cancer	6.74e-06	4.28e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—GSTA3—prostate cancer	6.56e-06	4.17e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PDHA1—prostate cancer	6.56e-06	4.17e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—UCP3—prostate cancer	6.56e-06	4.17e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—TCN2—prostate cancer	6.56e-06	4.17e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—SLC22A3—prostate cancer	6.26e-06	3.98e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—HSD3B1—prostate cancer	6.26e-06	3.98e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—GSTA4—prostate cancer	6e-06	3.82e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—TBXAS1—prostate cancer	6e-06	3.82e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—GSTA2—prostate cancer	5.85e-06	3.72e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—SULT1A1—prostate cancer	5.78e-06	3.67e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—ABCG5—prostate cancer	5.78e-06	3.67e-05	CbGpPWpGaD
Indapamide—CA4—Metabolism—AKT1—prostate cancer	5.74e-06	3.65e-05	CbGpPWpGaD
Indapamide—CA9—Metabolism—PIK3CA—prostate cancer	5.68e-06	3.61e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—GSTA1—prostate cancer	5.64e-06	3.59e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—HSD3B2—prostate cancer	5.58e-06	3.55e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—GSTO1—prostate cancer	5.58e-06	3.55e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—NAT2—prostate cancer	5.58e-06	3.55e-05	CbGpPWpGaD
Indapamide—CA2—Metabolism—AKT1—prostate cancer	5.5e-06	3.5e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PLCB2—prostate cancer	5.35e-06	3.4e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CYP2C18—prostate cancer	5.35e-06	3.4e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—LRP2—prostate cancer	5.35e-06	3.4e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—P4HB—prostate cancer	5.25e-06	3.34e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—SLC22A1—prostate cancer	5.1e-06	3.24e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—SULT2A1—prostate cancer	4.97e-06	3.16e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—MED12—prostate cancer	4.89e-06	3.11e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—GNG5—prostate cancer	4.85e-06	3.09e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—NCOA3—prostate cancer	4.68e-06	2.97e-05	CbGpPWpGaD
Indapamide—CA9—Metabolism—AKT1—prostate cancer	4.64e-06	2.95e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—HPGDS—prostate cancer	4.46e-06	2.84e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CYP2C19—prostate cancer	4.43e-06	2.82e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—ACHE—prostate cancer	4.33e-06	2.75e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—GSTT1—prostate cancer	4.33e-06	2.75e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CYP2A6—prostate cancer	4.28e-06	2.72e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—AKR1C3—prostate cancer	4.16e-06	2.65e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PRKACB—prostate cancer	4.14e-06	2.63e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CYP17A1—prostate cancer	4.1e-06	2.6e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—NCOA2—prostate cancer	3.9e-06	2.48e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—SLC5A5—prostate cancer	3.72e-06	2.37e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CYP2E1—prostate cancer	3.64e-06	2.31e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—NQO1—prostate cancer	3.6e-06	2.29e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—TH—prostate cancer	3.54e-06	2.25e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CYP1B1—prostate cancer	3.45e-06	2.19e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—GGT1—prostate cancer	3.34e-06	2.12e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—NCOA1—prostate cancer	3.29e-06	2.09e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CYP19A1—prostate cancer	3.24e-06	2.06e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—RXRA—prostate cancer	3.13e-06	1.99e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—COMT—prostate cancer	3.01e-06	1.92e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—GSTP1—prostate cancer	3e-06	1.91e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—ITPR1—prostate cancer	2.95e-06	1.88e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—TYMS—prostate cancer	2.79e-06	1.77e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—GSTM1—prostate cancer	2.76e-06	1.75e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—LPL—prostate cancer	2.71e-06	1.72e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CYP1A1—prostate cancer	2.61e-06	1.66e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—ERCC2—prostate cancer	2.59e-06	1.65e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—MTHFR—prostate cancer	2.44e-06	1.55e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PPARA—prostate cancer	2.39e-06	1.52e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CAV1—prostate cancer	2.25e-06	1.43e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PIK3CG—prostate cancer	2.05e-06	1.3e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—INS—prostate cancer	1.94e-06	1.23e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CREBBP—prostate cancer	1.9e-06	1.21e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PIK3CD—prostate cancer	1.8e-06	1.14e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—NOS3—prostate cancer	1.7e-06	1.08e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PIK3CB—prostate cancer	1.57e-06	9.97e-06	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PTGS2—prostate cancer	1.55e-06	9.88e-06	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PTEN—prostate cancer	1.36e-06	8.61e-06	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—EP300—prostate cancer	1.29e-06	8.22e-06	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PIK3CA—prostate cancer	9.56e-07	6.08e-06	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—AKT1—prostate cancer	7.81e-07	4.96e-06	CbGpPWpGaD
